{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Equilibrative nucleoside transporter ENT1 inhibitors", "item": "https://www.patentleaderboard.com/patent/8263592"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Equilibrative nucleoside transporter ENT1 inhibitors

Equilibrative nucleoside transporter ENT1 inhibitors

US Patent 8263592 · Granted Sep 11, 2012

Estimated economic value: $59,732,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridine rings containing derivatives as MALT1 inhibitors2025
Pyrazole derivatives as MALT1 inhibitors2024
Pyrimidine derivatives for the treatment of viral infections2023
(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxalin2022
Pyrrolo[3,2-d] pyrimidine derivatives for the treatment of viral infections and 2022
Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors2021
Pyrazole derivatives as MALT1 inhibitors2021
Substituted nucleoside analogues for use as PRMT5 inhibitors2021
Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors2021
Pyrazole derivatives as MALT1 inhibitors2021
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for t2020
Pyrimidine derivatives for the treatment of viral infections2020